welbournes

Class 3 Medicines Recall: Atomoxetine 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, 100mg Hard Capsules (Accord Healthcare Ltd) Drug alert number: EL (24)A/25 Date issued: 02 July 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall for: Atomoxetine 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, 100mg Hard Capsules (Accord Healthcare Ltd) [...]

The post MHRA Class 3 Medicines Recall: Atomoxetine 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, 100mg Hard Capsules (Accord Healthcare Ltd) appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (02/07/2024) confirmed the following list of final price concessions for June 2024. This announcement comes in the following month and follows the decision by DHSC to impose changes to concessions pricing from April 2024 to try to manage purchase margins. DHSC has applied its new margin reduction formula as [...]

The post DHSC’s June 2024 Price Concessions – Final Update appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (28/06/2024) confirmed the following list of price concessions for June 2024. This announcement comes late in the month and follows the decision to impose changes to concessions pricing from April 2024 to try to manage purchase margins. DHSC has applied its new margin reduction formula as a final [...]

The post DHSC’s June 2024 Price Concessions – 2nd Update appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (25/06/2024) confirmed the following initial list of price concessions for June 2024. This announcement comes late in the month and follows the decision to impose changes to concessions pricing from April 2024 to try to manage purchase margins. DHSC has applied its new margin reduction formula as a [...]

The post DHSC’s June 2024 Price Concessions – 1st Update appeared first on Community Pharmacy England.

1st July 2024: Updates to the further information hosted on the Medicines Supply Tool,  have been published.  Department of Health and Social Care (DHSC) has issued a medicine supply notification for Disopyramide (Rythmodan Retard®) 250mg modified-release tablets and disopyramide (Rythmodan®) 100mg capsules. MSN/2024/075 Tier 2 – medium impact Date of issue: 5th June 2024 Disopyramide [...]

The post Medicine Supply Notification: Disopyramide (Rythmodan Retard® ) 250mg modified-release tablets and disopyramide (Rythmodan® ) 100mg capsules. Updated appeared first on Community Pharmacy England.